Skip to main content
SpringerLink
Log in

Antimalarials: the cost of resistance

  • Drug Economics and Quality of Life
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Phillips M, Phillips-Howard PA. Economic implications of resistance to antimalarial drugs. Pharmacoeconomics 1996; 10: 225–238

    Article  PubMed  CAS  Google Scholar 

  2. British National Formulary No. 32. London: The Pharmaceutical Press, 1996 Sep: 271–8

  3. Mills A. Is malaria control a priority? Evidence from Nepal. Health Econ 1993; 2: 333–47

    Article  PubMed  CAS  Google Scholar 

  4. Foster SD. Pricing distribution and use of antimalarial drugs. Bull World Health Organ 1991; 69: 349–63

    PubMed  CAS  Google Scholar 

  5. Shapira A, Beales P, Holloran M. Malaria: living with drug resistance. Parasitol Today 1993; 9: 168–73

    Article  Google Scholar 

  6. Ettling M, Shepard D. Economic cost of malaria in Rwanda. Trop Med Parasitol 1991; 42: 214–8

    PubMed  CAS  Google Scholar 

  7. Bioland PB, Lackritz EM, Kazembe PM, et al. Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa. J Infect Dis 1993; 167: 932–7

    Article  Google Scholar 

  8. Sudre P, Breman J, McFarland D, et al. Treatment of chloroquine-resistant malaria in African children: a cost-effectiveness analysis. Int J Epidemiol 1992; 21(1): 146–54

    Article  PubMed  CAS  Google Scholar 

  9. Kaewsonthi S, Harding A. Cost and performance of malaria surveillance: the patients perspective. Southeast Asian J Trop Med Public Health 1986; 17: 406–12

    PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Antimalarials: the cost of resistance. Drugs Ther. Perspect 9, 13–16 (1997). https://doi.org/10.2165/00042310-199709060-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199709060-00005

Keywords

Search

Navigation